Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Soda ban at work shrinks waistlines? new study investigates

NCT ID NCT05972109

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a two-part approach to help employees lose belly fat and improve insulin sensitivity: a workplace ban on sugary drinks and a single counseling session. Over 600 full-time employees who drank at least three sugary beverages a week took part. Researchers measured changes in waist circumference and insulin sensitivity over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Workplace sales ban on sugary drinks and brief motivational counseling
What this could lead to
If successful, this approach could offer a simple, workplace-based strategy to help reduce obesity and improve metabolic health in employees.
What could go wrong
This is a completed study, but results may not apply to all workplaces or populations. The intervention is environmental and behavioral, so individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

604 people

The number who actually took part.

Started

Aug 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Full-time employee who works on campus at one of the Sutter Health participating sites * Speaks and reads English * Consumes three or more sugar-sweetened beverages (SSB) a week * Agrees to participate in two fasting blood draws Exclusion Criteria: * Pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insulin sensitivity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Insulin Resistance obesity disorder Obesity, Abdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insulin sensitivity Obesity, abdominal

Contacts and locations

Locations

  • Sutter Health/California Pacific Medical Center Research Institute

    San Francisco, California, 94115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.